Lisata Therapeutics, INC 8-K filings

NASDAQ

17 Apr 2024

LSTA

8-K: Lisata Therapeutics Appoints James Nisco as Senior Vice President, Finance and Treasury and Chief Accounting Officer

Lisata Therapeutics has appointed James Nisco as its new Senior Vice President, Finance and Treasury and Chief Accounting Officer, effective April 15, 2024.

NASDAQ

29 Feb 2024

LSTA

Lisata Therapeutics, INC

8-K: Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Lisata Therapeutics reports its full year 2023 financial results, highlighting the completion of enrollment in the Phase 2b ASCEND trial and reaffirming its operational funding projection into early 2026.